Is there a role for first generation TKIs in adjuvant setting of EGFR mutated early NSCLC?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Chinese clinical oncology - 12(2023), 3 vom: 01. Juni, Seite 30 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ospina, Aylen Vanessa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adjuvant therapy |
|---|
| Anmerkungen: |
Date Completed 10.07.2023 Date Revised 16.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.21037/cco-23-27 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358049423 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358049423 | ||
| 003 | DE-627 | ||
| 005 | 20231226073919.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21037/cco-23-27 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1193.xml |
| 035 | |a (DE-627)NLM358049423 | ||
| 035 | |a (NLM)37303222 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ospina, Aylen Vanessa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Is there a role for first generation TKIs in adjuvant setting of EGFR mutated early NSCLC? |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.07.2023 | ||
| 500 | |a Date Revised 16.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Epidermal growth factor receptor tyrosine kinase inhibitors | |
| 650 | 4 | |a adjuvant therapy | |
| 650 | 4 | |a early non-small cell lung cancer | |
| 650 | 7 | |a ErbB Receptors |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 650 | 7 | |a Protein Kinase Inhibitors |2 NLM | |
| 650 | 7 | |a EGFR protein, human |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 700 | 1 | |a Provencio, Mariano |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chinese clinical oncology |d 2012 |g 12(2023), 3 vom: 01. Juni, Seite 30 |w (DE-627)NLM233535675 |x 2304-3873 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:3 |g day:01 |g month:06 |g pages:30 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.21037/cco-23-27 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2023 |e 3 |b 01 |c 06 |h 30 | ||